Device Week, July 6, 2018–Clinical Data Presentations At ADA;Big Deals From GE, Novartis, Bio-Techne

In this edition of Device Week, Medtech Insight editor Marion Webb reports on the American Diabetes Association conference in Orlando and editor Reed Miller runs down the latest corporate restructuring news. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR m Medtech Insight articles addressing topics discussed in this episode: ADA2018: Insulet Reports Positive Clinical Results For Omnipod Horizon, Limited Market Release Of Dash https://bit.ly/2J0Ajd4 ADA2018: Senseonics' Implantable CGM Beats Abbott, Dexcom In Head-To-Head Study – But Is Methodology Flawed? https://bit.ly/2lXXBr6 ADA2018: Medtronic Touts Power of Artificial Intelligence, New Pediatric Indication, Payer Guarantee Program https://bit.ly/2KNXZGB GE Spins Off Healthcare As Part Of Major Reorganization https://bit.ly/2tylKbJ Bio-Techne Makes Big Push Into Liquid Biopsy With Exosome Acquisition https://bit.ly/2NuiJBZ Novartis Sees The Light And Plumps For Alcon Spin-Off https://bit.ly/2u9qxjo